DOD Peer Reviewed Cancer Translational New Investigator Award

The summary for the DOD Peer Reviewed Cancer Translational New Investigator Award Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	DOD Peer Reviewed Cancer Translational New Investigator Award
	CFDA Number:	12.420
	CFDA Description:	Military Medical Research and Development
	Federal Agency Name:	Dept of the Army USAMRAA
	Category of Funding Activity:	Science and Technology
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	W81XWH-10-PRCRP-TNIA
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement Grant
	Posted Date:	May 20, 2010
	Creation Date:	May 20, 2010
	Original Closing Date for Applications:	Oct 20, 2010
	Current Closing Date for Applications:	Oct 20, 2010
	Archive Date:	Nov 19, 2010
	Expected Number of Awards:	10
	Estimated Total Program Funding:	$4,500,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: Information not provided
Grant Description: The PRCRP Translational New Investigator Award mechanism is being offered for the first time in FY10. The Translational New Investigator Award supports the development of translational research partnerships among two independent investigators to address at least one of the FY10 PRCRP Topic Areas in a manner relevant to military beneficiaries. Within the partnership, one member must be a laboratory scientist and the other must be a clinician. This award is intended to support a mentoring partnership between a new investigator (the Principal Investigator [PI]) and a mentor (a clinician or laboratory scientist with an established research program in one of the FY10 PRCRP Topic Areas). The ultimate goal of translational research is to move an observation forward into a clinical application. Research does not have to be performed in the clinic but should include human anatomical substances. The Translational New Investigator Award supports preclinical studies in animal models and/or human anatomical substances that have clear potential for translation into clinical applications. Correlative studies that are associated with an existing clinical trial, and/or projects that develop clinical endpoints for clinical trials may be proposed. Developing the research plan must involve a reciprocal flow of ideas and information within the research team (from bench to bedside, and from bedside to bench). Research involving human subject participation is permitted under this funding opportunity but is restricted to studies without clinical trials. Clinical trials are not permitted under this award mechanism. In general, a clinical trial is defined as a prospective study where an intervention (e.g., a device, drug, behavioral, surgical procedure) is tested on human subjects for a measurable outcome. Correlative Human Subject Use (clinical research) studies are permitted, and the study may be associated with a clinical trial, but it does not seek the main outcomes of the clinical trial. Correlative studies are defined as a prospective or retrospective collection of human anatomical substances (tissue, blood, nail clippings, bone marrow, behavioral documentation, etc.) to be used in research to answer a question regarding the disease and /or interventions. Correlative studies do not include the direct testing for the outcome of any intervention for the prevention, diagnosis, treatment, or evaluation of the quality of life of the patient. Correlative Human Subject Use may require informed consent of the human subject, and may include identifiable information. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. For FY10, the PRCRP Translational New Investigator Award will only consider applications that address one or more of the following FY10 PRCRP Topic Areas.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP help Desk [cdmrp.pa@amedd.army.mil]
Similar Government Grants: • DOD FY11 Breast Cancer Research Program Clinical Translational Research Award; • DoD Peer Reviewed Orthopaedic Technology Development Award; • DoD Peer Reviewed Orthopaedic Translational Research Partnership Award; • DoD Peer Reviewed Orthopaedic Clinical Trial Award; • DoD Post-Traumatic Stress Disorder In-Home Therapy Clinical Trial Award; • FY2006 Deployed War Fighter Protection Research Program; • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)Concept Awa...; • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) Innovator ...; • Department of Defense (DOD) FY04 Breast Cancer Research Program (BCRP) Concept Award (CA); • Department of Defense Fiscal Year 2004 Breast Cancer Center of Excellence Award (COE)